Medtronic, Inc.

Boston Scientific Scimed, Inc.

Tsunami Medtech, LLC

Nxthera, Inc.

Vessix Vascular, Inc.

Other

University of Minnesota

Nuvasive, Inc.

Iotek, Inc.

Uptake Medical Corp.

Scimed Life Systems, Inc.

Minnow Medical, Inc.

Vessix, Inc.

Agricultural Solutions, Inc.

Hoey, Michael

Michael F Hoey

Peter M J Mulier

John H Shadduck

Mark Schrom

Roger Noel Hastings

Corbett W Stone

Peter M Mulier

Arthur Gerald Blanck

Steven Carlson

Richard H Comben

Steven M Goetz

Mark A Christopherson

Raphael Marie Michel

Rolfe Tyson Gustus

Mike Perry

Stephanos Paulos

Matthew Byrne

Randall James Beyreis

Grant Mauch

Bret Herscher

Tom A Steinke

Richard Charles Kravik

Marlene Kay Truesdale

Karliam C Woo

Kevin Thomas Foley

David E Francischelli

Rahul Mehra

Scott Eric Jahns

Robert Lawrence Barry

Lorraine E Reeve

Paul V Trescony

Dean T Corcoran

Brian Cran

James S Sharrow

Jon M Ocel

Sheldon K Lee

Frederick J Foley

Len Briggs

Adel M Medhkour

Jaydeep Yeshwant Kokate

Mark R Bilitz

Thomas A Steinke

Eric P Jerke

Eric M DoBrava

Suzana Prstic

Timothy D Byland

Paul Anthony Iaizzo

Scott Kimmel

David Eliezer Chasan

Meital Mazor

Ryan James Fenton

Shawn McCutcheon

Robert M Pearson

Thomas G Adelman

Peter Lyons

Peter Gehlbach

Maximillian D Fiore

Avram Bar-Cohen

Linas R Kunstmanas

Marwane S Berrada

Brian A Bachmeier

Ronda Elizabeth Schreiber

Brian D Conn

Jeffrey Bennett

Eric Jerke

Kevin J Desantis

Scott Kimmell

Philippe Marc Rabbat

Randall Beyreis

Eugene Scanlon

Peter MJ Mulier

A vapor delivery needle and method is provided that is adapted for treating prostate cancer. The energy delivery probe can apply condensable vapor energy to tissue, such as a peripheral zone tissue in a human prostate. In one method, a needle is introduced into peripheral zone tissue of a human prostate, and vapor media is delivered through the needle to ablate peripheral zone tissue without ablating non-peripheral zone tissue. Systems for treating prostate cancer with vapor therapy are also provided.

Systems and methods for treating prostate cancer

An energy delivery probe is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the energy can be applied with a vapor media. The energy delivery probe can include a vapor delivery member configured to extend into a transition zone prostate tissue. A condensable vapor media can be delivered from the vapor delivery member into the transition zone tissue, wherein the condensable vapor media can propagate interstitially in the transition zone tissue and be confined in the transition zone tissue by boundary tissue adjacent to the transition zone tissue. Methods associated with use of the energy delivery probe are also covered.

Systems and methods for prostate treatment

A catheter and catheter system can use energy tailored for remodeling and/or removal of target material along a body lumen, often of atherosclerotic material of a blood vessel of a patient. An elongate flexible catheter body with a radially expandable structure may have a plurality of electrodes or other electrosurgical energy delivery surfaces to radially engage atherosclerotic material when the structure expands. An atherosclerotic material detector system may measure and/or characterize the atherosclerotic material and its location, optionally using impedance monitoring.

Tuned RF energy and electrical tissue characterization for selective treatment of target tissues

A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.

Systems and methods for treatment of prostatic tissue

A vapor delivery system and method is provided that is adapted for treating prostate tissue. The vapor delivery system includes a vapor delivery needle configured to deliver condensable vapor energy to tissue. In one method, the vapor delivery system is advanced transurethrally into the patient to access the prostate tissue. The vapor delivery system is properly positioned by measuring and advancing the system based on a field-of-view of an endoscope or camera disposed within the system.

Systems and methods for treating the prostate

A vapor delivery system and method is provided that is adapted for treating prostate tissue. The vapor delivery system includes a vapor delivery needle configured to deliver condensable vapor energy to tissue. In one method, the vapor delivery system is advanced transurethrally into the patient to access the prostate tissue. The vapor delivery system includes a generator unit and an inductive heating system to produce a high quality vapor for delivery to tissue. Methods of use are also provided.

Vapor ablation systems and methods

A catheter and catheter system may be used to treat disease tissue by gentle heating in combination with gentle or standard dilation. An elongate flexible catheter body with a radially expandable balloon having a plurality of electrodes engage tissue including diseased tissue when the structure expands.

System for inducing desirable temperature effects on body tissue

Methods, systems and devices for applying energy to tissue, and more particularly relates to a system for ablating or modifying structures in a body with systems and methods that generate a flow of vapor at a controlled flow rate for applying energy to the body structure.

Medical system and method of use

A vapor delivery device is provided that may include any of a number of features. One feature of the vapor delivery device is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate tissues of the prostate. The vapor delivery device can include a handle portion and a cartridge portion. The cartridge portion can be configured to be inserted into a lumen of the handle portion to align and position a vapor coil of the cartridge portion within a RF coil of the handle portion. Methods associated with use of the energy delivery probe are also covered.

A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, or denature tissues of the prostate. Methods associated with use of the energy delivery probe are also covered.

Medical devices and methods

A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the vapor delivery needle can be advanced a predetermined distance into the prostate with a solenoid actuation mechanism. Methods associated with use of the energy delivery probe are also covered.

A vapor delivery system and method is provided that is adapted for ablating bladder tissue to treat overactive bladder (OAB). The vapor delivery system includes an anchor tip configured anchor the system in the bladder while condensable vapor is delivered to target tissue. In one method, the vapor delivery system is advanced transurethrally into the patient to access the target tissue of the bladder, which can include a surface sensor of the bladder responsible for creating an urge incontinence sensation. The vapor delivery system includes a vapor source that provides a high quality vapor for delivery to tissue.

Systems and methods for treating the bladder with condensable vapor

A vapor delivery system and method is provided that includes a number of features. In one embodiment, a method comprises inserting a vapor delivery needle into tissue of a patient, activating a flow of vapor from a vapor generator through vapor delivery ports of the vapor delivery needle to cause condensed liquid to exit vapor delivery ports of the vapor delivery needle, generating vapor in the vapor generator, delivering a dose of vapor through the vapor delivery ports of the vapor delivery needle into the tissue, and after the dose of vapor is delivered, re-activating the flow of vapor from the vapor generator through the vapor delivery ports of the vapor delivery needle to prevent a vacuum from forming in the vapor delivery needle. Vapor therapy systems are also provided.

Growing community of inventors

Shoreview, MN, United States of America

Michael F Hoey